Pradaxa 75 mg
Pradaxa 75 mg is a medicine authorised by Swissmedic under authorisation number 61385. The authorisation holder is Boehringer Ingelheim (Schweiz) GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 29 May 2012 and the authorisation is valid without a time limit. ATC code B01AE07 places the medicine in the group Antithrombotic agents.
| Authorisation number | 61385 |
|---|---|
| Name | Pradaxa 75 mg |
| Full name | Pradaxa 75 mg, Kapseln |
| Authorisation holder | Boehringer Ingelheim (Schweiz) GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | B01AE07 |
| First authorisation | 29 May 2012 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Pradaxa 75 mg, Kapseln | B | 29 May 2012 |
| 2 | Pradaxa 110 mg, Kapseln | B | 29 May 2012 |
| 3 | Pradaxa 150 mg, Kapseln | B | 29 May 2012 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 15 | 60 | Kapsel(n) | B01AE07 | 06.03.0. | B |
| 16 | 3 x 60 | Kapsel(n) | B01AE07 | 06.03.0. | B |
| 18 | 60 | Kapsel(n) | B01AE07 | 06.03.0. | B |
| 19 | 3 x 60 | Kapsel(n) | B01AE07 | 06.03.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Pradaxa 75 mg authorised in Switzerland?
Yes. Pradaxa 75 mg is authorised by Swissmedic under authorisation number 61385, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Pradaxa 75 mg have?
Pradaxa 75 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Pradaxa 75 mg?
The authorisation holder is Boehringer Ingelheim (Schweiz) GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.